Borderline products: how to tell if your product is a medicine

WHO recognition affirms MHRA’s commitment to regulatory excellence, innovation and global collaboration

LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing.

Professor Benger’s leadership comes at a pivotal time as the MHRA and NICE deepen collaboration

The internationally renowned expert in the calculation and communication of risk and statistics, Sir David Spiegelhalter, discusses the concept of a ‘preference zone’ to frame the demands of safety, efficacy and choice in the era of personalised medicine.

Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.

Due to risk of infection, non-sterile alcohol-free wipes are not appropriate for the treatment of injuries, wounds or on broken skin, nor for cleaning of intravenous lines.